We carried out a genome-wide association study of type-2 diabetes (T2D) in individuals of South Asian ancestry. Our discovery set included 5,561 individuals with T2D (cases) and 14,458 controls drawn from studies in London, Pakistan and Singapore. We identified 20 independent SNPs associated with T2D at P < 10 −4 for testing in a replication sample of 13,170 cases and 25,398 controls, also all of South Asian ancestry. In the combined analysis, we identified common genetic variants at six loci (GRB14, ST6GAL1, VPS26A, HMG20A, AP3S2 and HNF4A) newly associated with T2D (P = 4.1 × 10 −8 to P = 1.9 × 10 −11 ). SNPs at GRB14 were also associated with insulin sensitivity (P = 5.0 × 10 −4 ), and SNPs at ST6GAL1 and HNF4A were also associated with pancreatic beta-cell function (P = 0.02 and P = 0.001, respectively). Our findings provide additional insight into mechanisms underlying T2D and show the potential for new discovery from genetic association studies in South Asians, a population with increased susceptibility to T2D.
Individuals with South Asian ancestry are at an up to fourfold higher risk of T2D compared to European populations 1, 2 . T2D currently affects ~55 million South Asians worldwide and is projected to affect ~80 million South Asians by 2030 (ref. 3 ), which will comprise onequarter of all people with T2D worldwide. Though unhealthy diet, obesity and physical inactivity contribute to T2D, it also has an important genetic contribution 4 . T2D is heritable in South Asians, as it is in other populations 5 .
To date, genome-wide association studies (GWAS) have identified variants in and around 42 genes as associated with susceptibility to T2D 4 . However, these studies have been predominantly performed in populations of European ancestry. We therefore used genome-wide association to identify common genetic variants underlying risk of T2D in South Asians. The study design is shown in Figure 1 .
In stage one, we analyzed data from GWAS performed in 5,561 South Asian cases and 14,458 South Asian controls from the London Life Sciences Population (LOLIPOP) study 6 , the Pakistan Risk of Myocardial Infarction Study (PROMIS) 7 and the Singapore Indian Eye (SINDI) Study 8 using Illumina genotyping arrays. We identified South Asians as people with ancestry from the Indian subcontinent (India, Pakistan, Sri Lanka and Bangladesh). We summarized the characteristics of the participants and genotyping arrays used (Supplementary Note and Supplementary Table 1) . We excluded samples with <95% call rate as well as SNPs with call rate <97%, Hardy-Weinberg equilibrium P < 10 −6 or minor allele frequency <1%. We used principal components analysis to assess for population substructure 9 ; the results of this analysis confirmed that the GWAS samples were representative of South Asian ancestry with no evidence for stratification between cases and controls or between the three studies ( Supplementary Figs. 1 and 2) .
l e t t e r s
The primary analysis tested the association with T2D of the 568,976 autosomal SNPs that had been directly genotyped and passed quality control testing among the South Asian GWAS participants. We chose to limit the primary analysis to directly genotyped rather than imputed SNPs, as a South-Asian-specific dense haplotype map has not been described. This approach was enabled by the use of Illumina microarrays for all samples (17,880 samples on the Illumina 610 or 660 and 2,139 samples on the Illumina 317). We tested SNP associations with T2D separately among men and women in each study using logistic regression and an additive genetic model. We included principal components as covariates to adjust for population substructure 9 ; there were no other covariates used in the regression analyses. We combined the results from the separate studies using a fixed effects inverse variance meta-analysis implemented in METAL (see URLs) and output association test results adjusted for the genomic control inflation factor. There was no evidence for inflation of the test statistics (λ = 1.00 to λ = 1.03; Supplementary Table 2 and Supplementary Fig. 3 ).
In the primary analysis, one locus reached genome-wide significance (P < 5 × 10 −8 ); the lead SNP was rs7903146 in TCF7L2, which is a well described T2D risk variant (Fig. 2) 10 . There were a further 59 independent loci associated with T2D at P ≤ 1 × 10 −4 , of which 50 have not previously been described in GWAS of T2D (Supplementary Table 3 ). To help prioritize these loci for replication testing in stage two, we carried out a combined analysis of the South Asian discovery data with results from the DIAGRAM+ GWAS meta-analysis (8,130 cases with T2D and 38,987 controls of European ancestry) 11 . We then took forward for replication testing (i) all loci associated with T2D in South Asians alone at P ≤ 1 × 10 −5 (N = 7) and (ii) among the loci associated with T2D in South Asians at P > 1 × 10 −5 and P ≤ 1 × 10 −4 , the 12 independent SNPs with the lowest P values in the combined analysis with results from DIAGRAM+ (corresponding to ~P < 10 −3 ). This strategy was designed to maximize discovery of both genetic loci specific to South Asians as well as loci shared with European populations.
We carried out replication testing in 13,170 cases and 25,398 controls of South Asian ancestry (Supplementary Note and Supplementary Table 4) . We tested SNP associations with T2D separately in each cohort and then combined the results by inverse variance meta-analysis. Six SNPs were associated with T2D in the South Asian replication samples at P < 2.5 × 10 −3 (P < 0.05 after correction for multiple testing): rs3923113 near GRB14, rs16861329 in ST6GAL1, rs1802295 in VPS26A, rs2028299 near AP3S2, rs7178572 in HMG20A and rs4812829 in HNF4A ( Table 1, Supplementary Table 5 and Supplementary Fig. 4 ). These six SNPs reached genome-wide significance (P < 5 × 10 −8 ) in a combined analysis of GWAS data from South Asians and the results for South Asians from the replication samples (Table 1) .
Of the 12 SNPs with modest statistical evidence in the South Asian GWAS (P > 1 × 10 −5 and P ≤ 1 × 10 −4 ) that we carried forward for replication testing based on the combined analysis with the DIAGRAM+ data, 3 showed replication and reached genome-wide significance in South Asians. This lends support to the view that selection of SNPs based on a combined analysis with Europeans is likely to enrich for true associations.
As secondary analyses, we carried out the following five GWAS meta-analyses: (i) male-gender specific; (ii) female-gender specific; (iii) body mass index (BMI) adjusted; (iv) lean T2D cases (BMI < 25 kg/m 2 ) compared to overweight controls (BMI > 25 kg/m 2 ); and (v) analysis of GWAS data imputed with untyped SNPs from the HapMap2 reference panel (for a total of 2,646,472 SNPs). One locus reached P < 5 × 10 −8 for association with T2D among women ( Supplementary  Fig. 5 ). However, the sentinel SNP (rs17052370, near UBBP4, odds ratio (OR) = 1.37, 95% confidence interval (CI) 1.23-1.52, P = 8.9 × 10 −9 ) did not replicate among South Asian women either in the replication samples (OR = 1.03, 95% CI 0.97-1.09, P = 0.32) or in the combined analysis of the GWAS and replication data (OR = 1.10, 95% CI 1.04-1.15, P = 3.4 × 10 −4 ). There were no additional loci identified from the other secondary analysis (Supplementary Fig. 5 ).
Because overweight status and obesity are major risk factors for T2D 12 , we investigated whether the relationship of the sentinel SNPs with T2D might be mediated through adiposity. We found that the sentinel SNPs are not associated with BMI or waist-hip ratio in South Asians (Supplementary Table 6 ). Furthermore, the association of the sentinel SNPs with T2D is not materially influenced by additional adjustment for measures of obesity among South Asians in the replication samples (Supplementary Table 7 ). Adiposity therefore does not mediate the relationships between these SNPs and T2D.
To provide insight into the genetic mechanisms underlying the observed associations with T2D, we sequenced the six associated regions ( Figure 2 Manhattan plot for the primary South Asian genome-wide association analysis of men and women using directly genotyped SNPs. At the six new loci reaching genome wide-significance, the sentinel SNPs are indicated with a green dot for the GWAS result and a red dot for the combined analysis of the GWAS and replication data in South Asians. Combined analysis DIAGRAM+ Top SNP at 12/44 loci selected Figure 1 Summary of study design.
To investigate possible transcriptional mechanisms underlying our associations with T2D, we investigated the relationships of sentinel SNPs with cis-expression quantitative trait loci (eQTLs) in adipose tissue, liver, peripheral blood leucocytes and other tissues (Supplementary Table 9 ). At 2q24, rs3923113 is in high LD (r 2 = 0.85) with rs10195252, which was recently reported to be associated with central adiposity and increased expression of GRB14 in adipose tissue (P < 10 −10 ) 14 . At 15q26, rs2028299 is closely associated with expression of C15orf38 in skin and fat (P < 10 −16 ). At 15q24, rs7178572 is weakly associated with expression of PSTPIP1 but is in low LD (r 2 < 0.3) with the peak SNP associated with this eQTL; PSTPIP1 is unlikely to be the causal gene at this locus.
To test for heterogeneity between the participating South Asian GWAS cohorts, we compared effect sizes at (i) the loci identified in the present study and (ii) the 42 loci previously reported to be associated with T2D in GWAS. After correction for multiple testing, there was no evidence for heterogeneity of effect at any of these loci (Supplementary Table 10 ). Findings were similar among South Asians in the replication samples, although there was some evidence for heterogeneity at the GRB14 locus ( Supplementary Fig. 4 ). There was also no evidence for heterogeneity of effect between South Asian men and women except at rs17052370, which was suggested in the women-only gender-specific secondary analysis but which did not replicate (Supplementary Table 11 ).
We then investigated whether there was heterogeneity of effect between South Asians and Europeans. Among the 42 loci reported to be associated with T2D, 37 showed consistent direction of effect in South Asians and Europeans (P = 2.8 × 10 −8 ) and 27 were associated with T2D at P < 0.05 in South Asians only (Supplementary Table 12 ). Only three loci showed statistical evidence for heterogeneity of effect at P < 0.001 (P < 0.05 after correction for multiple testing). These findings support the view that the effects of common variants are largely shared between populations 6,15-17 and lend further support to the strategy of prioritizing SNPs from the South Asian GWAS through a combined analysis with results from Europeans. There was also no evidence for heterogeneity of effect between South Asians and Europeans at the six new loci discovered in the present study, including those carried forward for further testing based on GWAS results from South Asians only (Table 1) .
Finally, we compared the LD structure of the six loci in South Asians and Europeans (Supplementary Table 13 ). There was some evidence for different pairwise LD between the two populations at the VPS26A locus, however, these differences were small (Supplementary Fig. 6 ). At the GRB14, ST6GAL1, AP3S2, HMG20A and HNF4A loci, the haplotype structures were similar and there was no evidence for differences in pairwise LD between South Asians and Europeans.
We identify common variants at the six loci newly associated with T2D in individuals of South Asian ancestry. Regional plots of directly genotyped SNPs are shown in Figure 3 . Results for genotyped and imputed SNPs are shown in Supplementary Figures 7 and 8 , and the top ten SNPs (genotyped or imputed) at each locus are listed in Supplementary Table 14 . At the GRB14, VPS26A and HMG20A loci, the genotyped SNP is that most strongly associated with T2D. At the ST6GAL1, AP3S2 and HNF4A loci, there were imputed SNPs which had stronger P values than those for the directly genotyped SNPs. For the STGAL1 and AP3S2 loci, the sentinel genotyped SNP is in perfect LD with the lead imputed SNP. At HNF4A, the sentinel genotyped SNP (rs4812829) and the lead imputed SNP (rs4812831) are in partial LD (r 2 = 0.43). However, these LD estimates are calculated from HapMap European CEU data, so they may not be applicable to South Asians.
At 2q24, rs3923113 is closest to GRB14, which is a strong candidate for the observed association. GRB14 is an adaptor protein that binds l e t t e r s to insulin receptors and insulin-like growth-factor receptors to inhibit tyrosine kinase signaling 18, 19 . Grb14 −/− mice have higher lean mass, better glucose homeostasis despite lower insulin and improved insulin sensitivity 20 compared to wild type. The risk allele of rs3923113 is associated with T2D and with reduced insulin sensitivity in South Asians, suggesting a gain of function (Supplementary Table 6 ). rs3923113 is also in high LD (r 2 = 0.85) with rs10195252 (Supplementary Table 9 ), which was recently reported to be associated with central adiposity and expression of GRB14 in adipose tissue 14 . At 3q27, rs16861329 is intronic in ST6GAL1, which encodes an enzyme predominantly located in the Golgi apparatus. ST6GAL1 is involved in post-translational modification of cell-surface components by glycosylation. Although ST6GAL1 has not previously been linked with glucose metabolism or T2D, glycosylation through addition of sialic acid residues is reported to influence both insulin action and cell surface trafficking 21 . rs16861329 is also near ADIPOQ, which encodes adiponectin, a hormone secreted by adipocytes that promotes insulin sensitivity. Adiponectin knockout mice show severe insulin resistance 22 , and previous candidate gene studies have suggested an association of genetic variation at ADIPOQ with adiponectin levels, obesity and T2D 23 . However, these associations have not been consistently found, and rs16861329 (identified in the present study) is not in LD (r 2 < 0.1) with reported ADIPOQ variants.
At 10q22, rs1802295 is in VPS26A, which encodes a component of the retromer complex, a multimeric protein involved in transport of proteins from endosomes to the trans-Golgi network 24, 25 . VPS26A is expressed in pancreatic, adipose and other tissues 26 , but a relationship with glucose metabolism or T2D has not been described. At 15q26, rs2028299 is closest to AP3S2, which encodes a clathrin-associated adaptor complex expressed in adipocytes, pancreatic islets and other tissues that may be involved in vesicle transport and sorting 27 . rs2028299 is associated with expression of C15orf38, which encodes a member of an uncharacterized family of proteins. Among the other genes at this locus, PLIN1 is also a possible candidate for the association with T2D. PLIN1 encodes Perilipin-1, a phosphoprotein that coats fat droplets in adipocytes and regulates lipolysis by hormone-sensitive lipase 28 . Genetic variation at PLIN1 has been associated with obesity in humans and in experimental animal models 29, 30 . rs2028299 is 1.2 Mb from rs8042680 in PRC1, which is associated with T2D in Europeans 11 . Although these two SNPs are not in LD (r 2 = 0), we cannot exclude the possibility of a shared mechanism between the two through remote regulatory effects. At 15q24, known biology does not identify any compelling candidates. rs7178572 is intronic in HMG20A, which encodes a non-histone chromosomal protein that is widely expressed and which may influence histone methylation and be involved in neuronal development 31, 32 .
At 20q13, the lead genotyped SNP, rs4812829, is intronic in HNF4A, a strong candidate for the observed association. HNF4A is a nuclear transcription factor strongly expressed in liver 33 that regulates transcription of a number of genes including HNF1A 34 . Mutations in HNF4A are known to cause maturity-onset diabetes of the young type 1, which is characterized by defective pancreatic beta-cell function and impaired insulin secretion 35 . In keeping with this, the risk allele of rs4812829 is associated with reduced pancreatic beta-cell function in South Asians (Supplementary Table 9 ). At the HNF4A locus, there were four genotyped SNPs associated with T2D at P < 10 −5 ; in a conditional analysis, the effect sizes of these SNPs were substantially reduced, indicating that they are unlikely to be independent signals (Supplementary Table 15 ). An analysis of imputed data identified rs4812831 as the strongest signal at this locus (Supplementary Table 14) , suggesting that rs4812831 may either be the causal variant or be in high LD with it. The regional plots also show a separate cluster of SNPs associated with T2D that are not in LD with rs4812829 (with the lead SNP being rs12625067), raising the possibility of two separate causal variants at this locus. This is the first GWAS to investigate genetic factors underlying T2D in individuals of South Asian ancestry, a population with increased l e t t e r s
ONLINe MeThODS
Participants. South Asian T2D cases and controls. Genome-wide association was carried out among 5,561 South Asian cases with T2D and 14,458 South Asian controls from the London Life Sciences Population (LOLIPOP) study, the Pakistan Risk of Myocardial Infarction Study (PROMIS) and the Singapore Indian Eye (SINDI) study. Replication testing among South Asians was carried out in 13,170 cases and 25,398 control participants from the following studies: the Chennai Urban Rural Epidemiology Study (CURES) 37 , the COBRA study 38 , the Diabetes Genetics in Pakistan (DGP) and UK Asian Diabetes Study (UKADS) 39, 40 , the Mauritius study 41 , the Ragama Health Study (RHS) 42 , the Sikh Diabetes Study (SDS) 43 , the Singapore Consortium of Cohort Studies (SCCS), the Sri Lankan Diabetes Study (SLDS) 44 , and the LOLIPOP and PROMIS studies. For LOLIPOP and PROMIS, there was no overlap of participants between the genome-wide association and replication testing stages. Full details of the contributing cohorts are provided in the Supplementary Note along with the characteristics of the participants (Supplementary Tables 1 and 4) . European T2D cases and controls. Associations of SNPs with T2D in Europeans were tested in silico using results from the GWAS phase of the DIAGRAM+ study, which comprises 8,130 cases with T2D and 38,987 controls of European ancestry 11 . T2D case or control status was defined using study-specific criteria. SNP associations were tested using an additive genetic model and combined across studies by inverse variance meta-analysis using a fixed effects model.
Genotyping, quality control and statistical methods. Genome-wide association scans were performed using Illumina Infinium BeadChips, and genotypes were called using GenCall or Illuminus algorithms (Supplementary Table 1) . Samples with a SNP call rate <95% were removed, as were SNPs with call rate <97%, minor allele frequency <1%, or Hardy-Weinberg equilibrium P < 1.0 × 10 −6 . Hidden relatedness or duplicate samples were sought using identity-bydescent methods implemented in PLINK, and individuals with evidence for relatedness were excluded (pi_hat ≥ 0.5 in LOLIPOP and SINDI or pi_hat ≥ 0.37 in PROMIS to allow for the higher prevalence of consanguinuity in Pakistanis). In the absence of a South Asian-specific haplotype map, the primary analysis tested the association with T2D of the 568,976 autosomal SNPs that had been directly genotyped and passed quality control testing among the South Asian GWAS participants. As secondary analyses and to help fine map the loci identified, we repeated the GWAS analyses after imputation of untyped SNPs from HapMap2. Imputation of genotypes not directly measured was performed using pooled haplotypes from the CEU, YRI and CHB/JPT HapMap2 reference panels and the IMPUTE2 software package as previously described 45 .
Principal components analysis was used to identify population outliers by comparison to reference samples from the HapMap YRI, CHB, JPT and CEU panels and the Indian samples collected by Reich and colleagues 46 ; samples with eigenvalues inconsistent with South Asian ancestry were removed. Principal components analysis was performed in Eigensoft v3.0 (ref. 9) using a set of 100,864 SNPs common to all three studies and pruned to reduce pairwise LD-this SNP set was selected using the 'indep' option of PLINK (see URLs) with window size 50, step 3 and VIF = 1.3.
Associations of SNPs with T2D were tested using logistic regression and an additive genetic model. Analyses were carried out in men and women separately. Principal components were included as covariates to adjust for residual population stratification; no other covariate adjustments were made. The number of principal components included was study specific: for LOLIPOP we included ten, for PROMIS we included five and for SINDI we included three principal components. A fixed effects inverse variance meta-analysis was used to combine the results for the individual studies. The P values were adjusted for the study-level genomic control inflation factor before the metaanalysis and then again for the meta-analysis genomic control inflation factor (that is, a double genomic control correction) 47 .
The primary analysis comprised a meta-analysis of the association results for men and women combined at the 568,976 SNPs that had been directly genotyped. Secondary analyses included the following five GWAS metaanalyses: (i) male-gender specific; (ii) female-gender specific; (iii) BMI adjusted; (iv) lean cases (BMI < 25 kg/m 2 ) compared to overweight controls (BMI > 25 kg/m 2 ); and (v) analysis of GWAS data imputed with missing genotypes from the HapMap2 reference panel (for a total of 2,646,472 SNPs).
Selection for replication testing. SNPs that were located within a locus that had been previously reported to be associated with T2D were excluded, as were SNPs in LD (r 2 > 0.5) with another SNP that had a more significant association with T2D.
Twenty SNPs were carried forward for replication testing, comprising: (i) all SNPs associated with T2D at P ≤ 10 −5 in the primary South Asian-specific genome-wide association analysis of directly genotyped SNPs (N = 7); (ii) all SNPs associated with T2D at P < 5 × 10 −8 in one of the five secondary GWAS analyses (N = 1, identified from the female-gender-specific analysis); and (iii) 12 SNPs prioritized from among the 43 SNPs associated with T2D at P > 10 −5 and P ≤ 10 −4 in the primary analysis based on the lowest P value in a fixed effects inverse variance meta-analysis with results from the GWAS stage of the DIAGRAM+ study (corresponding to ~P < 10 −3 in the combined analysis) 11 .
Replication testing. Genotyping of the replication samples was performed by KASPAR (K-Bioscience Ltd), Sequenom MassArray or TaqMan assays (Supplementary Table 4) . Samples with <90% call rate were excluded, as were SNPs with call rate <95% or that deviated from Hardy-Weinberg equilibrium at P < 2.5 × 10 −3 . The associations of SNPs with T2D were tested in each cohort separately; heterogeneity between studies was assessed using a Cochran's Q statistic. A fixed effects meta-analysis was then used to combine the results for each SNP across all replication studies with available data and then in a combined analysis with results from the genome-wide association stage. Statistical significance was inferred at P < 2.5 × 10 −3 in the replication stage (P < 0.05 after Bonferroni correction for 20 SNPs). For the combined analysis of genome-wide and replication data, genome-wide significance was inferred at P < 5 × 10 −8 .
Power. For SNPs with minor allele frequency >20%, the study had >80% power to identify SNPs with odds ratios for T2D of OR > 1.11 per allele copy at P < 10 −4 in the genome-wide association phase, OR > 1.06 per allele copy at P < 2.5 × 10 −3 in the replication testing stage and OR > 1.08 per allele copy at P < 5 × 10 −8 in combined analysis.
Sequencing. Sequencing was performed using a Genome Analyzer II platform (Illumina) at the Beijing Genomics Institute with library preparation and a 91-bp paired-end sequencing strategy according to manufacturer's instructions. Reads were aligned to the human reference genome (NCBI Build 36) using Burrows-Wheeler alignment (BWA) 48 , duplicates were removed using SAMtools and the genotype likelihood was calculated by SOAPsnp 49 . We sequenced 109 South Asian samples (including 34 samples with T2D), and the average sequencing depth was ~4×.
Comparison of regional LD patterns. We used the varLD algorithm to compare the regional pattern of LD surrounding the index SNPs for each of the six regions 50 . The use of the targeted varLD algorithm tests the null hypothesis that the regional pattern of correlation between every pair of SNPs in the window is identical across two populations and yields a Monte Carlo P value that effectively quantifies the statistical evidence of a deviation from this identity. In our comparisons, we implemented 1,000 iterations for the Monte Carlo procedure across a 300-kb window around the associated SNPs in each region. Each analysis compares two of the following populations: (i) the 60 Europeans in phase 2 of HapMap (CEU); (ii) the 83 South Asians from the Singapore Genome Variation Project 36 ; and (iii) 60 randomly chosen control samples from the LOLIPOP study.
Expression QTLs. To determine whether the T2D risk variants detected in this study influenced expression of nearby genes, we accessed a variety of sources, including: (i) publicly available cis-eQTL data for brain 51, 52 , lymphoblastoid cell lines (LCLs) [53] [54] [55] , fibroblasts 55 , liver 56 and T cells 55 ; (ii) expression data from the MuTHER consortium 57 ; and (iii) cis-eQTL data for GRB14 reported in a recent GWAS of fat distribution 14 .
The MuTHER resource (see URLs) includes LCLs, skin and adipose tissue derived simultaneously from a subset of well phenotyped healthy female twins 57 . Whole-genome expression profiling of the samples, each with either two or three technical replicates, was performed using the Illumina Human HT-12 V3 BeadChips (Illumina Inc) according to the protocol supplied by
